VERNON HILLS, Ill.--(BUSINESS WIRE)--Applied NeuroSolutions, Inc. (OTC BB:APNS)(www.AppliedNeuroSolutions.com), a biotechnology Company focused on the development of products for the early diagnosis and treatment of Alzheimer’s disease (“AD”), today announced the achievement of a key milestone directed to a multi-product program to develop serum-based diagnostic tests for Alzheimer’s disease.
